Request for Covid-19 Impact Assessment of this Report
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Substance Abuse Treatment in these regions, from 2012 to 2022 (forecast).
United States Substance Abuse Treatment market competition by top manufacturers/players, with Substance Abuse Treatment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Alkermes
Allergan
GSK
Pfizer
Accord Healthcare
Amphastar Pharmaceuticals
Apotex
BioCorRx
Cipla
Glenmark
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Alcohol Abuse Treatment
Nicotine Abuse Treatment
Drug Abuse Treatment
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospitals
Clinics
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Substance Abuse Treatment Market Report 2017
1 Substance Abuse Treatment Overview
1.1 Product Overview and Scope of Substance Abuse Treatment
1.2 Classification of Substance Abuse Treatment by Product Category
1.2.1 United States Substance Abuse Treatment Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Substance Abuse Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Alcohol Abuse Treatment
1.2.4 Nicotine Abuse Treatment
1.2.5 Drug Abuse Treatment
1.3 United States Substance Abuse Treatment Market by Application/End Users
1.3.1 United States Substance Abuse Treatment Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 United States Substance Abuse Treatment Market by Region
1.4.1 United States Substance Abuse Treatment Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Substance Abuse Treatment Status and Prospect (2012-2022)
1.4.3 Southwest Substance Abuse Treatment Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Substance Abuse Treatment Status and Prospect (2012-2022)
1.4.5 New England Substance Abuse Treatment Status and Prospect (2012-2022)
1.4.6 The South Substance Abuse Treatment Status and Prospect (2012-2022)
1.4.7 The Midwest Substance Abuse Treatment Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Substance Abuse Treatment (2012-2022)
1.5.1 United States Substance Abuse Treatment Sales and Growth Rate (2012-2022)
1.5.2 United States Substance Abuse Treatment Revenue and Growth Rate (2012-2022)
2 United States Substance Abuse Treatment Market Competition by Players/Suppliers
2.1 United States Substance Abuse Treatment Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Substance Abuse Treatment Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Substance Abuse Treatment Average Price by Players/Suppliers (2012-2017)
2.4 United States Substance Abuse Treatment Market Competitive Situation and Trends
2.4.1 United States Substance Abuse Treatment Market Concentration Rate
2.4.2 United States Substance Abuse Treatment Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Substance Abuse Treatment Manufacturing Base Distribution, Sales Area, Product Type
3 United States Substance Abuse Treatment Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Substance Abuse Treatment Sales and Market Share by Region (2012-2017)
3.2 United States Substance Abuse Treatment Revenue and Market Share by Region (2012-2017)
3.3 United States Substance Abuse Treatment Price by Region (2012-2017)
4 United States Substance Abuse Treatment Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Substance Abuse Treatment Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Substance Abuse Treatment Revenue and Market Share by Type (2012-2017)
4.3 United States Substance Abuse Treatment Price by Type (2012-2017)
4.4 United States Substance Abuse Treatment Sales Growth Rate by Type (2012-2017)
5 United States Substance Abuse Treatment Sales (Volume) by Application (2012-2017)
5.1 United States Substance Abuse Treatment Sales and Market Share by Application (2012-2017)
5.2 United States Substance Abuse Treatment Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Substance Abuse Treatment Players/Suppliers Profiles and Sales Data
6.1 Alkermes
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Substance Abuse Treatment Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Alkermes Substance Abuse Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Allergan
6.2.2 Substance Abuse Treatment Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Allergan Substance Abuse Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 GSK
6.3.2 Substance Abuse Treatment Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 GSK Substance Abuse Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Pfizer
6.4.2 Substance Abuse Treatment Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Pfizer Substance Abuse Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Accord Healthcare
6.5.2 Substance Abuse Treatment Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Accord Healthcare Substance Abuse Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Amphastar Pharmaceuticals
6.6.2 Substance Abuse Treatment Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Amphastar Pharmaceuticals Substance Abuse Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Apotex
6.7.2 Substance Abuse Treatment Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Apotex Substance Abuse Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 BioCorRx
6.8.2 Substance Abuse Treatment Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 BioCorRx Substance Abuse Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Cipla
6.9.2 Substance Abuse Treatment Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Cipla Substance Abuse Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Glenmark
6.10.2 Substance Abuse Treatment Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Glenmark Substance Abuse Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
7 Substance Abuse Treatment Manufacturing Cost Analysis
7.1 Substance Abuse Treatment Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Substance Abuse Treatment
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Substance Abuse Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Substance Abuse Treatment Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Substance Abuse Treatment Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Substance Abuse Treatment Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Substance Abuse Treatment Sales Volume Forecast by Type (2017-2022)
11.3 United States Substance Abuse Treatment Sales Volume Forecast by Application (2017-2022)
11.4 United States Substance Abuse Treatment Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
Figure Product Picture of Substance Abuse Treatment
Figure United States Substance Abuse Treatment Market Size (K Units) by Type (2012-2022)
Figure United States Substance Abuse Treatment Sales Volume Market Share by Type (Product Category) in 2016
Figure Alcohol Abuse Treatment Product Picture
Figure Nicotine Abuse Treatment Product Picture
Figure Drug Abuse Treatment Product Picture
Figure United States Substance Abuse Treatment Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Substance Abuse Treatment by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Substance Abuse Treatment Market Size (Million USD) by Region (2012-2022)
Figure The West Substance Abuse Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Substance Abuse Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Substance Abuse Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Substance Abuse Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Substance Abuse Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Substance Abuse Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Substance Abuse Treatment Sales (K Units) and Growth Rate (2012-2022)
Figure United States Substance Abuse Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Substance Abuse Treatment Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Substance Abuse Treatment Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Substance Abuse Treatment Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Substance Abuse Treatment Sales Share by Players/Suppliers
Figure 2017 United States Substance Abuse Treatment Sales Share by Players/Suppliers
Figure United States Substance Abuse Treatment Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Substance Abuse Treatment Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Substance Abuse Treatment Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Substance Abuse Treatment Revenue Share by Players/Suppliers
Figure 2017 United States Substance Abuse Treatment Revenue Share by Players/Suppliers
Table United States Market Substance Abuse Treatment Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Substance Abuse Treatment Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Substance Abuse Treatment Market Share of Top 3 Players/Suppliers
Figure United States Substance Abuse Treatment Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Substance Abuse Treatment Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Substance Abuse Treatment Product Category
Table United States Substance Abuse Treatment Sales (K Units) by Region (2012-2017)
Table United States Substance Abuse Treatment Sales Share by Region (2012-2017)
Figure United States Substance Abuse Treatment Sales Share by Region (2012-2017)
Figure United States Substance Abuse Treatment Sales Market Share by Region in 2016
Table United States Substance Abuse Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Substance Abuse Treatment Revenue Share by Region (2012-2017)
Figure United States Substance Abuse Treatment Revenue Market Share by Region (2012-2017)
Figure United States Substance Abuse Treatment Revenue Market Share by Region in 2016
Table United States Substance Abuse Treatment Price (USD/Unit) by Region (2012-2017)
Table United States Substance Abuse Treatment Sales (K Units) by Type (2012-2017)
Table United States Substance Abuse Treatment Sales Share by Type (2012-2017)
Figure United States Substance Abuse Treatment Sales Share by Type (2012-2017)
Figure United States Substance Abuse Treatment Sales Market Share by Type in 2016
Table United States Substance Abuse Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Substance Abuse Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Substance Abuse Treatment by Type (2012-2017)
Figure Revenue Market Share of Substance Abuse Treatment by Type in 2016
Table United States Substance Abuse Treatment Price (USD/Unit) by Types (2012-2017)
Figure United States Substance Abuse Treatment Sales Growth Rate by Type (2012-2017)
Table United States Substance Abuse Treatment Sales (K Units) by Application (2012-2017)
Table United States Substance Abuse Treatment Sales Market Share by Application (2012-2017)
Figure United States Substance Abuse Treatment Sales Market Share by Application (2012-2017)
Figure United States Substance Abuse Treatment Sales Market Share by Application in 2016
Table United States Substance Abuse Treatment Sales Growth Rate by Application (2012-2017)
Figure United States Substance Abuse Treatment Sales Growth Rate by Application (2012-2017)
Table Alkermes Basic Information List
Table Alkermes Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alkermes Substance Abuse Treatment Sales Growth Rate (2012-2017)
Figure Alkermes Substance Abuse Treatment Sales Market Share in United States (2012-2017)
Figure Alkermes Substance Abuse Treatment Revenue Market Share in United States (2012-2017)
Table Allergan Basic Information List
Table Allergan Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Allergan Substance Abuse Treatment Sales Growth Rate (2012-2017)
Figure Allergan Substance Abuse Treatment Sales Market Share in United States (2012-2017)
Figure Allergan Substance Abuse Treatment Revenue Market Share in United States (2012-2017)
Table GSK Basic Information List
Table GSK Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Substance Abuse Treatment Sales Growth Rate (2012-2017)
Figure GSK Substance Abuse Treatment Sales Market Share in United States (2012-2017)
Figure GSK Substance Abuse Treatment Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Substance Abuse Treatment Sales Growth Rate (2012-2017)
Figure Pfizer Substance Abuse Treatment Sales Market Share in United States (2012-2017)
Figure Pfizer Substance Abuse Treatment Revenue Market Share in United States (2012-2017)
Table Accord Healthcare Basic Information List
Table Accord Healthcare Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Accord Healthcare Substance Abuse Treatment Sales Growth Rate (2012-2017)
Figure Accord Healthcare Substance Abuse Treatment Sales Market Share in United States (2012-2017)
Figure Accord Healthcare Substance Abuse Treatment Revenue Market Share in United States (2012-2017)
Table Amphastar Pharmaceuticals Basic Information List
Table Amphastar Pharmaceuticals Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amphastar Pharmaceuticals Substance Abuse Treatment Sales Growth Rate (2012-2017)
Figure Amphastar Pharmaceuticals Substance Abuse Treatment Sales Market Share in United States (2012-2017)
Figure Amphastar Pharmaceuticals Substance Abuse Treatment Revenue Market Share in United States (2012-2017)
Table Apotex Basic Information List
Table Apotex Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Apotex Substance Abuse Treatment Sales Growth Rate (2012-2017)
Figure Apotex Substance Abuse Treatment Sales Market Share in United States (2012-2017)
Figure Apotex Substance Abuse Treatment Revenue Market Share in United States (2012-2017)
Table BioCorRx Basic Information List
Table BioCorRx Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BioCorRx Substance Abuse Treatment Sales Growth Rate (2012-2017)
Figure BioCorRx Substance Abuse Treatment Sales Market Share in United States (2012-2017)
Figure BioCorRx Substance Abuse Treatment Revenue Market Share in United States (2012-2017)
Table Cipla Basic Information List
Table Cipla Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cipla Substance Abuse Treatment Sales Growth Rate (2012-2017)
Figure Cipla Substance Abuse Treatment Sales Market Share in United States (2012-2017)
Figure Cipla Substance Abuse Treatment Revenue Market Share in United States (2012-2017)
Table Glenmark Basic Information List
Table Glenmark Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Glenmark Substance Abuse Treatment Sales Growth Rate (2012-2017)
Figure Glenmark Substance Abuse Treatment Sales Market Share in United States (2012-2017)
Figure Glenmark Substance Abuse Treatment Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Substance Abuse Treatment
Figure Manufacturing Process Analysis of Substance Abuse Treatment
Figure Substance Abuse Treatment Industrial Chain Analysis
Table Raw Materials Sources of Substance Abuse Treatment Major Players/Suppliers in 2016
Table Major Buyers of Substance Abuse Treatment
Table Distributors/Traders List
Figure United States Substance Abuse Treatment Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Substance Abuse Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Substance Abuse Treatment Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Substance Abuse Treatment Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Substance Abuse Treatment Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Substance Abuse Treatment Sales Volume (K Units) Forecast by Type in 2022
Table United States Substance Abuse Treatment Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Substance Abuse Treatment Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Substance Abuse Treatment Sales Volume (K Units) Forecast by Application in 2022
Table United States Substance Abuse Treatment Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Substance Abuse Treatment Sales Volume Share Forecast by Region (2017-2022)
Figure United States Substance Abuse Treatment Sales Volume Share Forecast by Region (2017-2022)
Figure United States Substance Abuse Treatment Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...